Sensus Healthcare, Inc. (SRTS)
Stock Price:
$2.77 USD
-0.12 (-4.15%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
45.71M |
| Revenue (ttm) |
17.21M |
| Net Income (ttm) |
-5.85M |
| Shares Out |
16.50M |
| EPS (ttm) |
-0.37 |
| PE Ratio |
n/a |
| Forward PE |
25.19 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 23, 2020 |
| Last Price |
$2.77 |
| Previous Close |
$2.89 |
| Change ($) |
-0.12 |
| Change (%) |
-4.15% |
| Day's Open |
3.01 |
| Day's Range |
2.70 - 3.01 |
| Day's Volume |
4,672 |
| 52-Week Range |
1.76 - 5.84 |
More Stats
| Market Cap |
45.71M |
| Enterprise Value |
29.03M |
| Earnings Date (est) |
Oct 29, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
16.50M |
| Float |
11.40M |
| EPS (basic) |
-0.35 |
| EPS (diluted) |
-0.37 |
| FCF / Share |
0.07 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
2.37% |
| Payout Ratio |
n/a |
| Shares Short |
148,398 |
| Short Ratio |
6.73 |
| Short % of Float |
1.30% |
| Beta |
0.17 |
| PE Ratio |
n/a |
| Forward PE |
25.19 |
| P/FCF Ratio |
42.25 |
| PS Ratio |
2.66 |
| PB Ratio |
2.07 |
| Revenue |
17.21M |
| Operating Income |
-6.03M |
| Net Income |
-5.85M |
| Free Cash Flow |
1.08M |
| Net Cash |
16.69M |
| Net Cash / Share |
1.01 |
| Gross Margin |
102.00% |
| Operating Margin |
-35.05% |
| Profit Margin |
-34.00% |
| FCF Margin |
6.29% |
| ROA |
-11.50% |
| ROE |
-23.67% |
| ROIC |
-33.00% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (6)
| Buy |
6 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$5.07*
(83.03% upside)
Low
4.25
Current: $2.77
High
6.00
Target: 5.07
*Average 12-month price target from 6 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|
| Revenue | 27.26 | 26.43 | 20.59 | 14.81 | 10.27 | 5.81 | 10.48 |
| Revenue Growth | 3.16% | 28.36% | 39% | 44.17% | 76.81% | -44.55% | - |
| Gross Profit | 17.56 | 16.91 | 13.80 | 9.85 | 6.58 | 3.76 | 6.88 |
| Operating Income | -1.97 | -2.01 | -3.72 | -0.36 | -0.22 | -3.68 | 0.13 |
| Net Income | -1.70 | -2.02 | -3.71 | -0.35 | -0.24 | -3.70 | 0.11 |
| Shares Outstanding | 16.23 | 14.12 | 13.24 | 12.03 | 9.89 | 40.84 | 40.48 |
| Earnings Per Share | -0.10 | -0.14 | -0.28 | -0.03 | -0.08 | -103.76 | -10.02 |
| Operating Cash Flow | -2.11 | -8.56 | -3.06 | -0.85 | -1.34 | -1.87 | -0.13 |
| Capital Expenditures | -0.40 | -0.85 | -0.29 | -0.29 | -0.20 | -0.12 | -0.25 |
| Free Cash Flow | -2.51 | -9.42 | -3.34 | -1.14 | -1.54 | -1.99 | -0.38 |
| Cash & Equivalents | 15.59 | 15.40 | 11.21 | 11.53 | 5.09 | 4.56 | - |
| Total Debt | 1.43 | - | 2.21 | - | 0.42 | 0.38 | - |
| Net Cash / Debt | 14.17 | 15.40 | 9.00 | 11.53 | 4.67 | 4.19 | - |
| Assets | 36.92 | 33.25 | 18.84 | 18.95 | 9.64 | 6.94 | - |
| Liabilities | 8.92 | 6.79 | 7.15 | 3.67 | 3.71 | 2.80 | - |
| Book Value | 28.00 | 26.46 | 11.68 | 15.27 | 5.92 | 4.14 | - |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Sensus Healthcare, Inc. |
| Country |
United States |
| Employees |
53 |
| CEO |
Joseph C. Sardano |
Stock Information
| Ticker Symbol |
SRTS |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: SRTS |
| IPO Date |
June 3, 2016 |
Description
Sensus Healthcare manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary robotic intraoperative radiation therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.